MedPacto (XKRX:235980) Total Operating Expense : ₩15,838.1 Mil (TTM As of Mar. 2025)

View and export this data going back to 2019. Start your Free Trial

What is MedPacto Total Operating Expense?

MedPacto's Total Operating Expense for the three months ended in Mar. 2025 was ₩3,735.1 Mil. MedPacto's Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2025 was ₩15,838.1 Mil.

MedPacto Total Operating Expense Historical Data

The historical data trend for MedPacto's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MedPacto Total Operating Expense Chart

MedPacto Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Operating Expense

Get a 7-Day Free Trial

13,238.45

27,799.95

29,459.12

37,193.01

28,752.09

MedPacto Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Total Operating Expense	Get a 7-Day Free Trial															9,703.77	5,112.35	2,204.03	4,786.72	3,735.05

MedPacto Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.

Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩15,838.1 Mil.

MedPacto Total Operating Expense Related Terms

Thank you for viewing the detailed overview of MedPacto's Total Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

MedPacto Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » MedPacto Inc (XKRX:235980) » Definitions » Total Operating Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

92 Myeongdal -ro, Seocho-gu, Borim Building, Seoul, KOR

Website

http://www.medpacto.com

MedPacto Inc is a drug discovery and development company based in South Korea. It is engaged in developing anticancer drugs and medicines which focuses on therapeutics targeting cancer and autoimmune diseases. Its products are in pipeline.

MedPacto Headlines

No Headlines